Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of GDC-0919 alone and with atezolizumab in advanced solid tumors
jRCT2080223275Phase 1
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of navoximod in Nonhematologic neoplasms (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
navoximod
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080223275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223275.